Pulmonary complications of drug therapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000009:adverse effects; D002066:Busulfan / Q000009:adverse effects; D002648:Child; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006584:Hexamethonium Compounds / Q000009:adverse effects; D006801:Humans; D006852:Hydrochlorothiazide / Q000009:adverse effects; D008171:Lung Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008297:Male; D008464:Mecamylamine / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D008784:Methysergide / Q000009:adverse effects; D008875:Middle Aged; D009582:Nitrofurantoin / Q000009:adverse effects; D010406:Penicillins / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D010996:Pleural Effusion / Q000139:chemically induced; D011020:Pneumonia, Pneumocystis / Q000139:chemically induced; D011342:Procainamide / Q000009:adverse effects; D011654:Pulmonary Edema / Q000139:chemically induced / Q000000981:diagnostic imaging; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000000981:diagnostic imaging; D011859:Radiography; D013412:Sulfadimethoxine / Q000009:adverse effects
D000636:Aminosalicylic Acids; D006584:Hexamethonium Compounds; D010406:Penicillins; D006852:Hydrochlorothiazide; D013412:Sulfadimethoxine; D010672:Phenytoin; D008464:Mecamylamine; D009582:Nitrofurantoin; D002066:Busulfan; D011342:Procainamide; D008784:Methysergide; D008727:Methotrexate